D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 146 Citations 82,762 439 World Ranking 32 National Ranking 23
Medicine D-index 171 Citations 113,581 652 World Ranking 182 National Ranking 124
Best Scientists D-index 172 Citations 119,550 661 World Ranking 569 National Ranking 384

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

1999 - Fellow of the American Association for the Advancement of Science (AAAS)

1984 - Fellow of John Simon Guggenheim Memorial Foundation

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Gene
  • Internal medicine

Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Drug resistance are his primary areas of study. His research investigates the connection between Virology and topics such as Molecular biology that intersect with problems in Cell culture. His study in Viral load, Viral disease, Viremia, Lentivirus and Virus latency falls within the category of Immunology.

His Virus research incorporates elements of T cell, Peripheral blood mononuclear cell, Antibody and Sexual transmission. In Acquired immunodeficiency syndrome, Douglas D. Richman works on issues like Pharmacotherapy, which are connected to MEDLINE. His research investigates the link between Drug resistance and topics such as Drug that cross with problems in Disease.

His most cited work include:

  • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial. (2708 citations)
  • Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy (2466 citations)
  • Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. (1818 citations)

What are the main themes of his work throughout his whole career to date?

Douglas D. Richman mainly focuses on Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Zidovudine. His studies in Virology integrate themes in fields like Antibody, Drug resistance and Reverse transcriptase. Immunology and Peripheral blood mononuclear cell are frequently intertwined in his study.

His Virus research includes themes of RNA, Cell culture, In vitro and Molecular biology. His Acquired immunodeficiency syndrome study combines topics in areas such as Clinical trial, Internal medicine, Pharmacotherapy, Disease and Cohort. His research in Zidovudine intersects with topics in Lamivudine, AIDS-related complex, Indinavir and Chemotherapy.

He most often published in these fields:

  • Virology (74.53%)
  • Immunology (51.55%)
  • Virus (40.37%)

What were the highlights of his more recent work (between 2013-2021)?

  • Virology (74.53%)
  • Immunology (51.55%)
  • Viral load (20.37%)

In recent papers he was focusing on the following fields of study:

Douglas D. Richman mostly deals with Virology, Immunology, Viral load, Peripheral blood mononuclear cell and Viral replication. His study in Virology focuses on Virus and Viremia. His work in Immunology addresses issues such as Transcription, which are connected to fields such as Asymptomatic.

His Viral load research includes elements of Internal medicine, Interquartile range, Cohort study, Genotype and Drug resistance. His Cohort study research includes elements of Acquired immunodeficiency syndrome, Incidence and Cohort. His research in Peripheral blood mononuclear cell intersects with topics in Cytomegalovirus and Transplantation.

Between 2013 and 2021, his most popular works were:

  • Defective proviruses rapidly accumulate during acute HIV-1 infection. (381 citations)
  • Defective proviruses rapidly accumulate during acute HIV-1 infection. (381 citations)
  • International AIDS Society global scientific strategy: towards an HIV cure 2016 (268 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Internal medicine

Douglas D. Richman focuses on Immunology, Virology, Viral load, Viral replication and Peripheral blood mononuclear cell. His study involves Immune system, Virus latency, CD8, T cell and Antibody, a branch of Immunology. Virus and Emtricitabine are among the areas of Virology where the researcher is concentrating his efforts.

The concepts of his Viral load study are interwoven with issues in Cohort study, Resistance mutation, Lopinavir, Bone marrow and Lentivirus. His Viral replication research integrates issues from Asymptomatic and Transcription. Douglas D. Richman studied Peripheral blood mononuclear cell and RNA that intersect with DNA, CXCR3, In vitro, IL-2 receptor and Lymphatic system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb.
The New England Journal of Medicine (1987)

4437 Citations

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

Diana Finzi;Monika Hermankova;Theodore Pierson;Lucy M. Carruth.
Science (1997)

3234 Citations

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Joseph K. Wong;Marjan Hezareh;Huldrych F. Günthard;Diane V. Havlir.
Science (1997)

2329 Citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)

2322 Citations

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

Brendan A. Larder;Graham Darby;Douglas D. Richman.
Science (1989)

2007 Citations

Update of the Drug Resistance Mutations in HIV-1.

Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard.
Topics in HIV medicine : a publication of the International AIDS Society, USA (2008)

1940 Citations

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Victor Appay;P. Rod Dunbar;Margaret Callan;Paul Klenerman.
Nature Medicine (2002)

1753 Citations

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth.
The New England Journal of Medicine (1990)

1710 Citations

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

Douglas D. Richman;Terri Wrin;Susan J. Little;Christos J. Petropoulos.
Proceedings of the National Academy of Sciences of the United States of America (2003)

1544 Citations

Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar.
The New England Journal of Medicine (2002)

1512 Citations

Editorial Boards

Antiviral Therapy
(Impact Factor: 1.679)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Douglas D. Richman

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 348

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 275

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 274

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 259

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 228

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 217

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 203

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 199

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 171

David C. Montefiori

David C. Montefiori

Duke University

Publications: 166

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 154

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 152

John W. Mellors

John W. Mellors

University of Pittsburgh

Publications: 152

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 150

Davey M. Smith

Davey M. Smith

University of California, San Diego

Publications: 147

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic

Publications: 141

Trending Scientists

Karim R. Lakhani

Karim R. Lakhani

Harvard University

Covadonga Pevida

Covadonga Pevida

Spanish National Research Council

Andreas Greiner

Andreas Greiner

University of Bayreuth

Petra Schwille

Petra Schwille

Max Planck Society

Mariastella Scandola

Mariastella Scandola

University of Bologna

Ian A. Blair

Ian A. Blair

University of Pennsylvania

Peng Gao

Peng Gao

Harbin Engineering University

Albertina P. Lima

Albertina P. Lima

National Institute of Amazonian Research

Paul Ahlquist

Paul Ahlquist

University of Wisconsin–Madison

Øjvind Moestrup

Øjvind Moestrup

University of Copenhagen

Stanislav Kopriva

Stanislav Kopriva

University of Cologne

Lisa M. Frenkel

Lisa M. Frenkel

Seattle Children's Hospital

Vassilis Amiridis

Vassilis Amiridis

Aristotle University of Thessaloniki

Bruce A. Albrecht

Bruce A. Albrecht

University of Miami

Clive P. Duncan

Clive P. Duncan

University of British Columbia

Alicia K. Matthews

Alicia K. Matthews

University of Illinois at Chicago

Something went wrong. Please try again later.